Seragon Pharmaceuticals Investor Relations Manager Salary | Comparably
Seragon Pharmaceuticals develops small-molecule drugs for the treatment of estrogen receptor dependent breast cancer. read more
EMPLOYEE
PARTICIPANTS
4
TOTAL
RATINGS
106

Seragon Pharmaceuticals Investor Relations Manager Salary

The average Seragon Pharmaceuticals Investor Relations Manager earns an estimated $97,175 annually. Seragon Pharmaceuticals' Investor Relations Manager compensation is $9,872 more than the US average for a Investor Relations Manager.

The Communications Department at Seragon Pharmaceuticals earns $9,929 more on average than the Enterprise Risk Department.

Last updated 5 years ago.

$51k
$64k
$75k
$85k
$114k
$175k
$97,175
Average Compensation
$97,175
avg. base

Investor Relations Manager Salaries at Seragon Pharmaceuticals

* estimated salary

Compensation at Seragon Pharmaceuticals by Department

The Communications Department averages $9,929 more than the Enterprise Risk Department.

Communications
$195,641 Avg. total comp.
Enterprise Risk
$185,712 Avg. total comp.
-$10k
Product
$151,052 Avg. total comp.
-$45k

Investor Relations Manager Compensation by Gender (All Companies)

The average female Investor Relations Manager at companies similar size to Seragon Pharmaceuticals reported making $152,500, while the average male Investor Relations Manager at similar sized companies reported making $75,500.

Investor Relations Manager Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Investor Relations Manager at companies similar size to Seragon Pharmaceuticals reported making $175,000, while the average Caucasian Investor Relations Manager at similar sized companies reported making $70,250.

How Investor Relations Managers at Seragon Pharmaceuticals Rate Their Compensation

The majority of Investor Relations Managers at Seragon Pharmaceuticals believe they're compensated fairly. 50% of Investor Relations Managers at Seragon Pharmaceuticals say they receive annual bonuses, and the majority (67%) are satisfied with their benefits. See more compensation ratings at Seragon Pharmaceuticals

×
Rate your company